Mangalam Drugs And Organics balance sheet

As of Mar 2026

Total assets: ₹315cr−14.0% on Mar 2025
Shareholders' equity: ₹103cr−30.8% on Mar 2025
Total debt: ₹105cr+30.0% on Mar 2025
Cash and investments: ₹0.7cr−72.9% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	116	134	104	108
	0.0	0.0	0.0	6.4
	39.4	29.1	20.8	15.2
	3.9	2.7	7.7	3.1
	0.0	0.0	0.0	—
	0.0	0.1	—	—
	0.0	0.1	0.0	—
	0.3	1.9	25.0	—
	159	167	158	—
	103	139	124	137
	40.3	39.1	27.9	46.5
	0.7	2.6	0.9	2.7
	0.0	0.0	0.0	0.0
	0.1	1.1	1.2	—
	3.2	5.5	4.7	7.3
	44.2	48.2	34.7	—
	8.7	11.9	17.3	12.6
	156	199	176	—
	315	366	333	360
Equity
	15.8	15.8	15.8	15.8
	87.2	133	120	136
	103	149	136	—
	103	149	136	—
Liabilities
	8.6	9.2	13.4	18.8
	0.0	2.5	5.1	—
	8.6	11.7	18.5	—
	5.2	9.8	12.1	14.5
	1.6	4.3	3.3	—
	15.3	25.8	33.8	—
	96.9	71.9	74.6	49.6
	75.9	91.1	65.9	97.1
	7.3	12.5	13.9	6.3
	180	176	154	—
	1.4	1.1	1.0	1.3
	—	0.9	0.0	0.4
	15.1	13.9	8.4	3.5
	197	192	164	—
	212	217	198	—
	315	366	333	360
Trade payables — MSME split
	12.1	7.3	—	—
	63.8	83.9	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

MANGALAM₹29.11

Mangalam Drugs And Organics Limited

· Pharma & Health

₹ CrorePeersBIOFILCHEM LASA VINEETLAB ORTINGLOBE KREBSBIO ALPA BALPHARMA NATCAPSUQMcap ₹46.1 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	107.6	104.2	133.6	115.7	115.7
+ Capital Work-in-Progress	6.4	0.0	0.0	0.0	0.0
+ Other Intangibles	15.2	20.8	29.1	39.4	39.4
+ Intangibles under Development	3.1	7.7	2.7	3.9	3.9
+ Non-current Investments	—	0.0	0.0	0.0	0.0
+ Other Non-current Financial Assets	—	—	0.1	0.0	0.0
Non-current Financial Assets	—	0.0	0.1	0.0	0.0
+ Other Non-current Assets	—	25.0	1.9	0.3	0.3
Total Non-current Assets	—	157.7	167.4	159.3	159.3
Current Assets
+ Inventories	137.5	123.6	138.8	102.8	102.8
+ Trade Receivables	46.5	27.9	39.1	40.3	40.3
+ Cash & Cash Equivalents	2.7	0.9	2.6	0.7	0.7
+ Other Bank Balances	0.0	0.0	0.0	0.0	0.0
+ Short-term Loans	—	1.2	1.1	0.1	0.1
+ Other Current Financial Assets	7.3	4.7	5.5	3.2	3.2
Current Financial Assets	—	34.7	48.2	44.2	44.2
+ Other Current Assets	12.6	17.3	11.9	8.7	8.7
Total Current Assets	—	175.7	199.0	155.7	155.7
Total Assets	359.6	333.4	366.4	315.0	315.0
Equity
+ Equity Share Capital	15.8	15.8	15.8	15.8	15.8
+ Other Equity / Reserves	136.1	120.0	133.2	87.2	87.2
Equity — Owners of Parent	—	135.8	149.0	103.1	103.1
Total Equity	—	135.8	149.0	103.1	103.1
Liabilities
+ Borrowings — Non-current	18.8	13.4	9.2	8.6	8.6
+ Other Non-current Financial Liab	—	5.1	2.5	0.0	0.0
Non-current Financial Liabilities	—	18.5	11.7	8.6	8.6
+ Deferred Tax Liabilities	14.5	12.1	9.8	5.2	5.2
+ Other Non-current Liabilities	—	3.3	4.3	1.6	1.6
Non-current Liabilities	—	33.8	25.8	15.3	15.3
+ Borrowings — Current	49.6	74.6	71.9	96.9	96.9
+ Trade Payables	97.1	65.9	91.1	75.9	75.9
+ Other Current Financial Liab	6.3	13.9	12.5	7.3	7.3
Current Financial Liabilities	—	154.4	175.6	180.1	180.1
+ Provisions — Current	1.3	1.0	1.1	1.4	1.4
+ Current Tax Liabilities	0.4	0.0	0.9	—	—
+ Other Current Liabilities	3.5	8.4	13.9	15.1	15.1
Current Liabilities	—	163.8	191.6	196.6	196.6
Total Liabilities	—	197.6	217.4	211.9	211.9
Total Equity & Liabilities	359.6	333.4	366.4	315.0	315.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	7.3	12.1	12.1
+ Dues to Other Creditors — Current	—	—	83.9	63.8	63.8

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.